Oxford University has announced its trial for a COVID-19 vaccine will resume after getting the green light from safety regulators. Trials were suspended last week after it was reported a United Kingdom patient had experienced adverse side-effects. The Australian Government signed an agreement with Oxford University’s partner, pharmaceutical company AstraZeneca, to secure the vaccine for Australians if trials are successful.